108 results
6-K
EX-99.1
BLU
Bellus Health Inc
2 Jun 23
Notice of Annual and Special Meeting of Shareholders
4:25pm
the intermediary holding shares on your behalf. By choosing to send these materials to you directly, the Company (and not the intermediary holding on your behalf … ) has assumed responsibility for (i) delivering these materials to you, and (ii) executing your proper voting instructions. Please return your voting
6-K
EX-99.1
BLU
Bellus Health Inc
19 May 23
Current report (foreign)
5:27pm
HEALTH INC. UNANIMOUSLY RECOMMENDS THAT SHAREHOLDERS VOTE
FOR
THE ARRANGEMENT RESOLUTION
May 16, 2023
These materials are important and require your … of this Circular and the Meeting materials may also be found on the Company’s website at www.bellushealth.com and under the Company’s profile on SEDAR
6-K
EX-99.1
BLU
Bellus Health Inc
16 May 23
BELLUS Health Inc. Calls Special Shareholders’ Meeting in Connection with GSK Acquisition
5:04pm
information circular and related meeting materials on or about May 26, 2023, at which time they will also be available on the Company’s profile
6-K
EX-99.2
BLU
Bellus Health Inc
12 May 23
Condensed Consolidated Interim Financial Statements of
4:32pm
of raw materials, equipment, labor and transportation;
our expectations regarding the protection of our intellectual property and our ability to secure … be caused by the ongoing COVID-19 pandemic;
the absence of interruption or delays in the operations of our suppliers of components or raw materials
6-K
EX-99.1
BLU
Bellus Health Inc
12 May 23
BELLUS Health Reports First Quarter 2023 Financial Results and Business Highlights
4:02pm
. ET. Following the ATS 2023 International Conference, the presentation materials will be available in the “Scientific Publications” section of BELLUS … -24, 2023. The presentation materials are available in the “Scientific Publications” section of BELLUS Health's website here.
FINANCIAL RESULTS
Cash
6-K
EX-99.1
5m8 xt26b
28 Apr 23
Report of Foreign Private Issuer for the Month of April 2023
3:01pm
6-K
EX-99.1
ushz7b0johwitn nutya
28 Apr 23
Report of Foreign Private Issuer for the Month of April 2023
11:13am
6-K
EX-99.2
net ws3h10b5kwu66
27 Apr 23
Material Change Report
6:04am
6-K
EX-99.1
y4yddv 9hyn5
26 Apr 23
BELLUS Health Announces Meeting Updates
6:00pm
6-K
EX-99.1
xry0s994kfor
24 Apr 23
Report of Foreign Private Issuer for the Month of April 2023
7:05pm
6-K
EX-99.2
sn2xfb x3
30 Mar 23
Notice of Annual and Special Meeting of Shareholders
11:22am
6-K
EX-99.1
4vf8y8pj6nmm 9gpe
30 Mar 23
Notice of Annual and Special Meeting of Shareholders
11:22am
6-K
EX-99.1
mt0dosb5c sskb4hb4
29 Mar 23
Current report (foreign)
5:26pm
6-K
EX-99.2
y9rp4
14 Nov 22
Condensed Consolidated Interim Financial Statements of
5:26pm
SUPPL
t86gdyyw47qgtngw6qv3
14 Nov 22
Supplemental materials (foreign)
5:25pm
6-K
EX-99.1
djugny4bb3msht5 9lxb
14 Nov 22
Open Market Sale Agreementsm
5:19pm
6-K
EX-99.1
3h127d5j
14 Nov 22
BELLUS Health Reports Third Quarter 2022 Financial Results and Business Highlights
4:03pm
6-K
EX-99.1
np7151ruzvlm0
11 Oct 22
BELLUS Health to Present Clinical Data from Phase 2b SOOTHE Trial of BLU-5937 at the CHEST Annual Meeting
7:00am
F-10
peyg620e3dq5fmwpq9
26 Aug 22
Registration of securities (Canada)
4:48pm
6-K
EX-99.1
yj0694a9hm
22 Aug 22
Bellus Health Inc. 6-K
7:01am